UHS|Analyst Targets
UHS|Company Info
UHS|Insider Trading
UHS|Fundamentals
UHS|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $5.16 | - | - |
| Q2'26 | $6.01 | $5.98 | -0.4% |
| Q1'26 | $5.89 | $5.62 | -4.6% |
| Q4'25 | $5.96 | $5.88 | -1.3% |
| Q3'25 | $4.95 | $5.69 | +14.9% |
| Q2'25 | $4.96 | $5.35 | +8.0% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $4.8B | - | - |
| Q2'26 | $4.6B | $4.6B | +0.3% |
| Q1'26 | $4.6B | $4.5B | -1.8% |
| Q4'25 | $4.5B | $4.5B | -1.3% |
| Q3'25 | - | $4.5B | - |
| Q2'25 | - | $4.3B | - |
UHS|Monthly Returns
Market Data
UHS Stock Snapshot
- Market cap
- 10.48B
- P/E ratio
- 6.9
- Day range
- $179.96 – $186.90
- News sentiment
- 46/100 · Neutral
- Analyst target
- $194.94 (+4.4%)
- Consensus
- Hold · 27 analysts
The technical read on UHS is balanced, which usually means the market is waiting on a catalyst. In Healthcare, names this size usually take direction from sector flows before company-level news.
Reverse DCF
What growth is priced into UHS?
At today's price, Universal Health Services, Inc. needs to grow free cash flow about -4.7% a year for the next 10 years to justify its valuation at a 6.67% cost of capital. Over its actual history it has compounded free cash flow at 5.0% a year, so the market is asking for 9.7 percentage points below its own delivered rate. On that basis UHS looks priced below what its own growth record supports.
- Implied FCF growth
- -4.7%
- Historical FCF CAGR
- 5.0%
- Growth gap
- -9.7 pts
- Verdict
- CHEAP
- Discount rate (WACC)
- 6.67%
- Beta
- 0.66
Behaviour On Record
What UHS's own history says about today's numbers
- Realized volatility (21d)
- 21.4% 31st pct
- Below its peak
- -26.7%
- vs 200-day average
- -0.1%
- Up days (1y)
- 49%
Universal Health Services, Inc. is currently running 21.4% annualised volatility over the last 21 sessions. Measured against UHS's own 13 years of daily returns rather than a market-wide average, that is the 31st percentile — on the quiet side for this stock, against a typical reading of 25.1%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.
UHS is trading -26.7% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -24.0%, and the deepest was -54.2% in 2020. The current drawdown is already deeper than this stock's typical annual low point, which puts it in the part of its range where past recoveries began — and where past declines also continued.
Price sits -0.1% from its 200-day moving average. Against every other day in its history, that gap ranks at the 42nd percentile — close to the gap it normally carries. Over the past year UHS closed higher on 49% of sessions, and it is currently 4 sessions into a rising streak.
On October specifically: over 13 years of records, UHS finished the month higher 5 of 13 times, with a median return of -0.3% and an average of -0.5%. Its strongest month historically has been July at +5.1% on average, its weakest September at -2.0%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.
Overnight risk is measurable too: UHS has opened more than 2% away from the prior close in 119 of 3,267 sessions (3.6% of the time), with the largest gaps running +7.2% and -11.6%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.
Across the last 3 dated reports on file, UHS moved an average of 7.8% in the session after earnings, closing higher 1 of those 3 times, with a median move of -4.4% and a largest of -10.7%.
All figures computed from 3,268 daily closes between 2013-10-15 and 2026-10-13, split-adjusted, recomputed daily. Percentiles are against UHS's own 13-year history, not a peer group or index.
Sector Rotation
Is money rotating into or out of UHS's sector?
Universal Health Services, Inc. sits in the Health Care sector, currently ranked 2nd of 12 GICS sectors by relative-strength rotation score (leading).
- Sector rank
- #2 of 12
- Sector state
- Leading
- Sector rotation score
- 91
Analyst Rating Changes
Are analysts turning bullish or bearish on UHS?
Leerink Partners most recently reiterated its rating on Universal Health Services, Inc. to Outperform on Sep 18, 2026 with a price target of $205 (from $198). Over the last 90 days, coverage has run 0 upgrades against 0 downgrades, a net mixed lean.
- Latest action
- Leerink Partners — Outperform
- 90-day upgrades
- 0
- 90-day downgrades
- 0
- Net rating momentum
- 0
Peers & ETF holders
UHS peers & ETF holders
Medical Care FacilitiesMarket cap · today
- UHSYou're here$10.5B+4.28%
- HCAHCA Healthcare, Inc.$99.2B+2.24%
- DVADaVita Inc.$11.7B-0.72%
News Sentiment Analysis
Sentiment gathered from recent headlines
Recent News Coverage
Most recent articles, ranked by recency (click to expand).
Technical Analysis
Real-time indicators across multiple timeframes
| Manager | Trend | Shares Held | % of Co. | Position Value | Filed |
|---|---|---|---|---|---|
| Vanguard Group Inc | ▼ Sell | 6,486,542 | 11.08% | $1.41B | 2026-01-29 |
| BlackRock, Inc. | ▼ Sell | 4,059,826 | 6.93% | $603.66M | 2026-08-07 |
| Geode Capital Management, LLC | ▲ Buy | 1,974,065 | 3.37% | $293.15M | 2026-08-12 |
| Invesco Ltd. | ▲ Buy | 1,951,147 | 3.33% | $290.12M | 2026-08-14 |
| FMR LLC (Fidelity) | ▲ Buy | 1,416,755 | 2.42% | $210.66M | 2026-08-13 |
| Norges Bank | ▼ Sell | 888,499 | 1.52% | $132.11M | 2026-08-12 |
| Morgan Stanley | ▲ Buy | 749,754 | 1.28% | $111.48M | 2026-08-13 |
| Goldman Sachs Group Inc | ▼ Sell | 601,953 | 1.03% | $89.50M | 2026-08-14 |
| AQR Capital Management LLC | ▼ Sell | 523,210 | 0.89% | $76.89M | 2026-08-14 |
| Northern Trust Corp | ▼ Sell | 450,821 | 0.77% | $67.03M | 2026-08-13 |
| Millennium Management LLC | ▼ Sell | 417,369 | 0.71% | $62.06M | 2026-08-14 |
| Citadel Advisors LLC | ▲ Buy | 308,147 | 0.53% | $45.82M | 2026-09-02 |
| Bridgewater Associates, LP | ▲ Buy | 228,121 | 0.39% | $33.92M | 2026-08-14 |
| Moore Capital Management, LP | ▲ Buy | 222,422 | 0.38% | $33.07M | 2026-08-14 |
| JPMorgan Chase & Co | ▼ Sell | 198,975 | 0.34% | $29.60M | 2026-08-12 |
| Bank of America Corp | ▼ Sell | 184,007 | 0.31% | $27.36M | 2026-08-14 |
| D. E. Shaw & Co., Inc. | ▲ Buy | 145,250 | 0.25% | $21.60M | 2026-08-14 |
| Squarepoint Ops LLC | ▲ Buy | 143,095 | 0.24% | $21.28M | 2026-08-14 |
| Susquehanna International Group, LLP | ▲ Buy | 125,808 | 0.21% | $18.71M | 2026-08-14 |
| Citigroup Inc | ▲ Buy | 121,209 | 0.21% | $18.02M | 2026-08-03 |
| Gotham Asset Management, LLC | ▼ Sell | 99,927 | 0.17% | $14.86M | 2026-08-14 |
| Wells Fargo & Company | ▼ Sell | 89,193 | 0.15% | $13.26M | 2026-08-14 |
| AllianceBernstein L.P. | ▲ Buy | 73,775 | 0.13% | $13.20M | 2026-08-14 |
| Prudential Financial Inc | ▲ Buy | 81,639 | 0.14% | $12.14M | 2026-08-12 |
| Man Group plc | ▲ Buy | 66,995 | 0.11% | $9.96M | 2026-08-14 |
| Member | Chamber | State | Type | Amount | Traded | Filed |
|---|---|---|---|---|---|---|
| Alan Armstrong | Senate | OK | ▲ Buy | $1K - $15K | 2026-03-27 | 2026-07-21 |
| Julia Letlow | House | LA05 | ▲ Buy | $1K - $15K | 2025-10-23 | 2026-01-13 |
| Julia Letlow | House | LA05 | ▼ Sell | $1K - $15K | 2025-01-24 | 2026-01-13 |